Literature DB >> 17785859

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.

Philip Bejon1, Jedidah Mwacharo, Oscar Kai, Stephen Todryk, Sheila Keating, Brett Lowe, Trudie Lang, Tabitha W Mwangi, Sarah C Gilbert, Norbert Peshu, Kevin Marsh, Adrian V S Hill.   

Abstract

Epidemiological observations suggest that T cell immunity may be suppressed in malaria-endemic areas. In vitro studies, animal models, and limited data in humans link immunosuppression with malaria, malnutrition, and other parasitic infections. However, there are no data to determine whether malaria-induced immunosuppression is significant in the long-term, or relative data comparing it with other factors in malaria-endemic areas, so as to measure the impact of malaria, other parasitic disease, nutritional status, age. and location on the acquisition and longevity of IFN-gamma responses in children in Kenya. We studied these factors in two cohorts of 1- to 6-year-old children in a malaria-endemic area. T cell responses were induced by vaccination in one cohort, and acquired as a result of natural exposure in a second cohort. Serial ELISPOT assays conducted over a 1-year period measured the induction and kinetics of IFN-gamma production in response to the malaria Ag thrombospondin-related adhesion protein. Induced responses in both cohorts and the longevity of response in the vaccinated cohort were fitted to potential explanatory variables. Parasitemia was prospectively associated with reduced IFN-gamma-producing T cells in both cohorts (by 15-25%), and both parasitemia and episodes of febrile malaria were associated with 19 and 31% greater attrition of T cell responses, respectively. Malaria may reduce the efficacy vaccinations such as bacillus Calmette-Guérin and investigational T cell-inducing vaccines, and may delay the acquisition of immunity following natural exposure to malaria and other pathogens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785859      PMCID: PMC2658805          DOI: 10.4049/jimmunol.179.6.4193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guérin vaccination in northern Malawi.

Authors:  Sian Floyd; Jorg M Pönnighaus; Lyn Bliss; Prince Nkhosa; Lifted Sichali; Glyn Msiska; Paul E M Fine
Journal:  J Infect Dis       Date:  2002-08-12       Impact factor: 5.226

2.  Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.

Authors:  Katie L Flanagan; Tabitha Mwangi; Magdalena Plebanski; Kennedy Odhiambo; Amanda Ross; Eric Sheu; Moses Kortok; Brett Lowe; Kevin Marsh; Adrian V S Hill
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

3.  Immunosuppression in children with malaria.

Authors:  B M Greenwood; A M Bradley-Moore; A D Bryceson; A Palit
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

Review 4.  Exploiting worm and allergy models to understand Th2 cytokine biology.

Authors:  Thirumalai R Ramalingam; Rachael M Reiman; Thomas A Wynn
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-10

5.  T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria.

Authors:  H C Whittle; J Brown; K Marsh; B M Greenwood; P Seidelin; H Tighe; L Wedderburn
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

6.  Assessment of severe malnutrition among hospitalized children in rural Kenya: comparison of weight for height and mid upper arm circumference.

Authors:  James Berkley; Isaiah Mwangi; Karen Griffiths; Ismail Ahmed; Sadik Mithwani; Mike English; Charles Newton; Kathryn Maitland
Journal:  JAMA       Date:  2005-08-03       Impact factor: 56.272

7.  Cutaneous delayed-type hypersensitivity responsiveness in patients during and after Plasmodium falciparum and Plasmodium vivax infections.

Authors:  D S Walsh; S Looareesuwan; S Vaniganonta; C Viravan; H K Webster
Journal:  Clin Immunol Immunopathol       Date:  1995-10

8.  Spatial and temporal heterogeneity of Anopheles mosquitoes and Plasmodium falciparum transmission along the Kenyan coast.

Authors:  Charles M Mbogo; Joseph M Mwangangi; Joseph Nzovu; Weidong Gu; Guiyan Yan; James T Gunter; Chris Swalm; Joseph Keating; James L Regens; Josephat I Shililu; John I Githure; John C Beier
Journal:  Am J Trop Med Hyg       Date:  2003-06       Impact factor: 2.345

9.  Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men.

Authors:  Vasee S Moorthy; Egeruan B Imoukhuede; Sheila Keating; Margaret Pinder; Daniel Webster; Michael A Skinner; Sarah C Gilbert; Gijs Walraven; Adrian V S Hill
Journal:  J Infect Dis       Date:  2004-05-24       Impact factor: 5.226

10.  Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

Authors:  J Geginat; F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  46 in total

1.  A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria.

Authors:  Tiffany Sun; Thomas Holowka; Yan Song; Swen Zierow; Lin Leng; Yibang Chen; Huabao Xiong; Jason Griffith; Mehdi Nouraie; Philip E Thuma; Elias Lolis; Chris J Janse; Victor R Gordeuk; Kevin Augustijn; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

2.  Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

Authors:  Jessica R Loughland; Gabriela Minigo; Julie Burel; Peta E Tipping; Kim A Piera; Fiona H Amante; Christian R Engwerda; Michael F Good; Denise L Doolan; Nicholas M Anstey; James S McCarthy; Tonia Woodberry
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

3.  Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.

Authors:  Ann M Moormann; Peter Odada Sumba; Kiprotich Chelimo; Hua Fang; Daniel J Tisch; Arlene E Dent; Chandy C John; Carole A Long; John Vulule; James W Kazura
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

Review 4.  Natural regulatory T cells in malaria: host or parasite allies?

Authors:  Diana S Hansen; Louis Schofield
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

5.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

6.  MIG and the regulatory cytokines IL-10 and TGF-β1 correlate with malaria vaccine immunogenicity and efficacy.

Authors:  Susanna J Dunachie; Tamara Berthoud; Sheila M Keating; Adrian V S Hill; Helen A Fletcher
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

7.  Distinct patterns of blood-stage parasite antigens detected by plasma IgG subclasses from individuals with different level of exposure to Plasmodium falciparum infections.

Authors:  Cathrine Holm Olesen; Karima Brahimi; Brian Vandahl; Susana Lousada-Dietrich; Prajakta S Jogdand; Lasse S Vestergaard; Daniel Dodoo; Peter Højrup; Michael Christiansen; Severin Olesen Larsen; Subhash Singh; Michael Theisen
Journal:  Malar J       Date:  2010-10-26       Impact factor: 2.979

8.  Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.

Authors:  Tonia Woodberry; Alberto Pinzon-Charry; Kim A Piera; Yawalak Panpisutchai; Christian R Engwerda; Denise L Doolan; Ervi Salwati; Enny Kenangalem; Emiliana Tjitra; Ric N Price; Michael F Good; Nicholas M Anstey
Journal:  Malar J       Date:  2009-06-07       Impact factor: 2.979

9.  Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults.

Authors:  Arlene E Dent; Kiprotich Chelimo; Peter O Sumba; Michele D Spring; Brendan S Crabb; Ann M Moormann; Daniel J Tisch; James W Kazura
Journal:  Malar J       Date:  2009-07-16       Impact factor: 2.979

10.  Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

Authors:  Jedidah Mwacharo; Susanna J Dunachie; Oscar Kai; Adrian V S Hill; Philip Bejon; Helen A Fletcher
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.